Zdrowie i gospodarka · 07/02/2002

FDA Requests Public Comment on Revised Draft Guidance for Medical Imaging Drugs and Biologics

The Food and Drug Administration (FDA) is seeking public input on a revised draft guidance for the development of medical imaging drugs and biologics, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.